Indications for and Findings on Transthoracic Echocardiography in COVID-19

Indications for and Findings on Transthoracic Echocardiography in COVID-19 JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY Jain, S. S., Liu, Q., Raikhelkar, J., Fried, J., Elias, P., Poterucha, T. J., DeFilippis, E. M., Rosenblum, H., Wang, E. Y., Redfors, B., Clerkin, K., Griffin, J. M., Abdalla, M., Bello, N. A., Hahn, R. T., Shimbo, D., Weiner, S. D., Kirtane, A. J., Kodali, S. K., Burkhoff, D., Rabbani, L. E., Schwartz, A., Leon, M. B., Homma, S., Di Tullio, M. R., Sayer, G., Uriel, N., Anstey, D. 2020; 33 (10): 1278-1284

Abstract

Despite growing evidence of cardiovascular complications associated with coronavirus disease 2019 (COVID-19), there are few data regarding the performance of transthoracic echocardiography (TTE) and the spectrum of echocardiographic findings in this disease.A retrospective analysis was performed among adult patients admitted to a quaternary care center in New York City between March 1 and April 3, 2020. Patients were included if they underwent TTE during the hospitalization after a known positive diagnosis for COVID-19. Demographic and clinical data were obtained using chart abstraction from the electronic medical record.Of 749 patients, 72 (9.6%) underwent TTE following positive results on severe acute respiratory syndrome coronavirus-2 polymerase chain reaction testing. The most common clinical indications for TTE were concern for a major acute cardiovascular event (45.8%) and hemodynamic instability (29.2%). Although most patients had preserved biventricular function, 34.7% were found to have left ventricular ejection fractions = 50%, and 13.9% had at least moderately reduced right ventricular function. Four patients had wall motion abnormalities suggestive of stress-induced cardiomyopathy. Using Spearman rank correlation, there was an inverse relationship between high-sensitivity troponin T and left ventricular ejection fraction (? = -0.34, P = .006). Among 20 patients with prior echocardiograms, only two (10%) had new reductions in LVEF of >10%. Clinical management was changed in eight individuals (24.2%) in whom TTE was ordered for concern for acute major cardiovascular events and three (14.3%) in whom TTE was ordered for hemodynamic evaluation.This study describes the clinical indications for use and diagnostic performance of TTE, as well as findings seen on TTE, in hospitalized patients with COVID-19. In appropriately selected patients, TTE can be an invaluable tool for guiding COVID-19 clinical management.

View details for DOI 10.1016/j.echo.2020.06.009

View details for Web of Science ID 000576958500018

View details for PubMedID 32782131

View details for PubMedCentralID PMC7298489